Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 120 for Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF).
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF): 0 warning letters, 120 recalls, 0 approval records, 0 Form 483s.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Side by side
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) — Warning letters0
Philips North America — Warning letters0
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) — Recalls120
Philips North America — Recalls355
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) — Approval records0
Philips North America — Approval records0
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) — Form 483s0
Philips North America — Form 483s0
Timeline
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Most recent FDA action: June 28, 2023
Full history →Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed July 17, 2026. https://argushq.ai/compare/medtronic-inc-cardiac-rhythm-and-heart-failure-crhf-vs-philips-north-america
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗